Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.70
+0.29 (5.36%)
At close: Aug 13, 2025, 4:00 PM
5.71
+0.01 (0.18%)
After-hours: Aug 13, 2025, 7:11 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 800 employees as of December 31, 2024. The number of employees increased by 300 or 60.00% compared to the previous year.
Employees
800
Change (1Y)
300
Growth (1Y)
60.00%
Revenue / Employee
$80,745
Profits / Employee
-$811,415
Market Cap
2.48B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RXRX News
- 8 days ago - Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th - GlobeNewsWire
- 19 days ago - How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma - Benzinga
- 22 days ago - Top 2 Health Care Stocks You May Want To Dump This Quarter - Benzinga
- 5 weeks ago - What's Happening With RXRX Stock? - Forbes
- 2 months ago - Recursion to lay off 20% of workforce, narrows focus amid biotech downturn - Reuters
- 2 months ago - MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy - GlobeNewsWire